In this comprehensive analysis, ATRIP reached exome-wide significance for the first time, with protein-truncating variants conferring a statistically significant association with increased breast cancer risk, comparable in magnitude to other moderate-penetrance genes such as BARD1. This evidence concerns the gene BARD1 and breast carcinoma.